Anastomosis Device Industry worth $4.4 billion by 2027, with a CAGR of 8.3%
The report "Anastomosis Device Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable, Automated), and Surgical Sealants and Adhesives, Application (CVDs, GI Surgeries) and End Users - Global Forecast to 2027", is projected to reach 4.4 billion by 2027 from USD 3.0 billion in 2022, at a CAGR of 8.3% during the forecast period.
Browse 289 market data Tables and 42 Figures spread through 305 Pages and in-depth TOC on "Anastomosis Device Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable, Automated), and Surgical Sealants and Adhesives, Application (CVDs, GI Surgeries) and End Users - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/anastomosis-device-market-5343963.html
The increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, the growing demand for minimally invasive surgeries, and technological advancements are the major factors driving the anastomosis device market’s growth. Emerging economies such as China, Japan, and India are providing profitable opportunities for the players operating in the anastomosis device market.
“Surgical Staplers segment accounted for the largest share of the anastomosis device market, by product.”
The anastomosis device market is segmented into surgical staplers, surgical sutures, and surgical sealants & adhesives. In 2021, the surgical staplers segment accounted for the largest share of the anastomosis device market. The surgical staplers market is further segmented into manual and powered surgical staplers. In 2021, the manual surgical staplers segment accounted for the largest share of the surgical staplers market. The large share of this segment can be attributed to the wide range of advantages associated with these devices, such as ease of use, minimal risk of complications like blood loss/leakage, shorter operating time, and reduced hospital costs.
“Cardiovascular & Thoracic Surgery accounted for the largest share in the market, by application.”
The anastomosis device market has been segmented into cardiovascular & thoracic surgery, gastrointestinal surgery, orthopaedic surgery, gynaecological surgery, and other applications. In 2021, the cardiovascular & thoracic surgery segment accounted for the largest share of the temperature monitoring market. Market growth can largely be attributed to the many cardiovascular surgeries performed across the globe because of the high incidence of cardiovascular disease (CVD), the increasing number of coronary and percutaneous cardiology interventions, and the growing adoption of anastomosis devices in these surgical procedures.
“Hospitals segment accounted for the largest share in the market, by end users.”
The anastomosis device market has been segmented into hospitals, ambulatory surgery centers, and other end users. In 2021, hospitals are estimated to be the largest end users of the anastomosis device market. The large share of this segment can be attributed to the increasing number of complex surgeries performed in hospitals, the growing geriatric population, favourable reimbursement policies for hospital treatments, and the growing number of new hospitals, especially in emerging countries.
“North America is the largest regional market for anastomosis devices.”
The global anastomosis device market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the anastomosis device market. The large share of North America in the global market can be attributed to the positive reimbursement scenario in the US, the rising incidence of cancer, and the implementation of a new funding model for Canadian hospitals.
The key players in anastomosis device market are Johnson & Johnson (US), Medtronic Plc (Ireland), B. Braun Melsungen (Germany), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), Artivion, Inc. (US), Smith & Nephew Plc (UK), Becton, Dickinson and Company (US), CONMED Corporation (US), Advanced Medical Solutions Group Plc (UK), Baxter International, Inc. (US), Teleflex (US), Meril Life Sciences (India), Surgical Specialties Corporation (US), Péters Surgical (France), DemeTECH Corporation (US), Purple Surgical (UK), Internacional Farmacéutica S.A. de C.V. (Mexico), BioSintex (Romania), Lotus Surgicals (India), Mellon Medical (Netherlands), and Frankenman International (China), EndoEvolution (US), Welfare Medical (UK) and Unisur Lifecare (India).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Anastomosis Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
